AJCN Tufts Nutrition Symposium, Boston Sept 24-26
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rebouche, C. J.
Right arrow Articles by Nelson, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rebouche, C. J.
Right arrow Articles by Nelson, S. E.
Agricola
Right arrow Articles by Rebouche, C. J.
Right arrow Articles by Nelson, S. E.

American Journal of Clinical Nutrition, Vol 52, 820-824, Copyright © 1990 by The American Society for Clinical Nutrition, Inc


ORIGINAL RESEARCH COMMUNICATIONS

Role of carnitine in utilization of dietary medium-chain triglycerides by term infants

CJ Rebouche, DD Panagides and SE Nelson
Department of Pediatrics, University of Iowa College of Medicine, Iowa City 52242.

The role of carnitine in oxidation of dietary medium-chain fatty acids (as medium-chain triglycerides) was studied in term human infants. Infants were fed, alternately, formulas with fat content that was predominantly long-chain triglycerides, or 40% medium-chain triglycerides. Urinary acylcarnitine excretion was significantly higher and the ratio of free to total carnitine was significantly lower when infants were fed the formula with medium-chain triglycerides. Two groups of 10 infants were fed a commercial soy-protein-based formula modified to contain 40% of fat calories as medium-chain triglycerides and with or without added L-carnitine. By 56 d, infants fed the formula without added L-carnitine excreted significantly more medium-chain dicarboxylic acids than did the same infants at 28 d and significantly more than infants consuming the carnitine-supplemented formula at either 28 or 56 d. Results are consistent with a role for carnitine in metabolism of dietary medium-chain triglycerides in infants.


This article has been cited by other articles:


Home page
J. Nutr.Home page
J. Odle
New Insights into the Utilization of Medium-Chain Triglycerides by the Neonate: Observations from a Piglet Model
J. Nutr., June 1, 1997; 127(6): 1061 - 1067.
[Abstract] [Full Text]


Home page
J Child NeurolHome page
P. R. Borum
Carnitine in Neonatal Nutrition
J Child Neurol, November 1, 1995; 10(2_suppl): 2S25 - 2S31.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by The American Society for Nutrition